BeStock  
Stocks › Biotechnology › DFTX

Definium Therapeutics DFTX

US equityMarket cap rank #2233Biotechnology
$28.34 −$1.14 (-3.87%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $28.05 -1.02%
Open$29.14
Prev close$29.48
Day range$28.18 – $29.51
Volume3.24M
Market cap$3.88B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership93.1%+5.56 pts vs. prior quarter
Institutions holding435+18 vs. prior quarter
Insider trades (recent)36 buys / 14 sellsNet buying
Short interest7.16% of floatDays to cover 5.8 · as of 30 Oct 2026
Short-sale volume share24.8%5-day average of daily volume

Short-sale volume as % of daily volume

12%19%26%34%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$6.48M (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

−$6.6MSuper+$148.9KBig+$2.7MMid+$2.7MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 33.6% of shares outstanding.

Largest holders

  • BlackRock8.60%
  • Capital Research8.21%
  • FMR6.59%
  • Avoro Capital Advisors LLC5.25%
  • Driehaus Capital Management LLC5.00%
  • Janus Henderson Group plc4.10%
  • T. Rowe Price Group, Inc.3.40%
  • Geode Capital Management, LLC2.66%

By investor type

  • Mutual Fund62.74%
  • Hedge Fund20.81%
  • VC/PE Fund4.78%
  • Public Company2.32%
  • Individual/Insider1.21%
  • Endowment Fund0.67%
  • Insurance Company0.64%
  • Private Company0.47%

Reported short interest has risen from 6.68% to 7.16% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
FMR Mutual Fund 2026/Q3 +4,272,378 6.6%
Capital Research Mutual Fund 2026/Q3 +2,905,074 8.2%
Barclays PLC Public Company 2026/Q3 +547,966 0.4%
BlackRock Mutual Fund 2026/Q3 +539,761 8.6%
Ensign Peak Advisors Inc. Endowment Fund 2026/Q3 +447,626 0.7%
UBS Asset Management Mutual Fund 2026/Q3 +429,202 0.8%
Lord, Abbett & Co. LLC Mutual Fund 2026/Q3 +539,476 0.4%
Capital Research Mutual Fund 2026/Q3 +8,331,133 6.2%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +4,582,031 3.4%
FMR Mutual Fund 2026/Q3 +2,943,158 3.5%
BlackRock Mutual Fund 2026/Q3 +2,752,604 8.4%
Avoro Capital Advisors LLC Hedge Fund 2026/Q3 +2,188,888 5.3%
Janus Henderson Group plc Mutual Fund 2026/Q3 +2,059,604 4.1%
AllianceBernstein Mutual Fund 2026/Q3 +1,711,584 1.3%
Wellington Management Group Mutual Fund 2026/Q3 +1,644,985 2.2%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
24 Sep 2026 Mark Sullivan Chief Legal Officer Automatic Disposition -14,051 $36.57 253,603
24 Sep 2026 Brandi Roberts Chief Financial Officer Automatic Disposition -3,377 $36.57 263,278
24 Sep 2026 Matthew Wiley Chief Commercial Officer Automatic Disposition -3,097 $36.57 8,411
24 Sep 2026 Robert Barrow Chief Executive Officer Automatic Disposition -31,550 $36.57 444,340
24 Sep 2026 Daniel Karlin Chief Medical Officer Automatic Disposition -10,853 $36.57 574,096
17 Sep 2026 Carol Vallone Independent Chairperson Derivative Exercise and Retained +1,086 $35.52 18,797
17 Sep 2026 Andreas Krebs Independent Vice Chairperson Derivative Exercise and Retained +1,629 $35.52 17,903
13 Sep 2026 Mark Sullivan Chief Legal Officer Other Acquisition +125,000 – 267,654
13 Sep 2026 Brandi Roberts Chief Financial Officer Other Acquisition +125,000 – 266,655
13 Sep 2026 Matthew Wiley Chief Commercial Officer Other Acquisition +125,000 – 362,133
13 Sep 2026 Robert Barrow Chief Executive Officer Other Acquisition +750,000 – 1,768,750
13 Sep 2026 Daniel Karlin Chief Medical Officer Other Acquisition +200,000 – 584,949
2 Sep 2026 Robert Barrow Chief Executive Officer Automatic Disposition -19,023 $37.94 450,890
1 Sep 2026 Robert Barrow Chief Executive Officer Other Acquisition +40,000 – 450,890
11 Aug 2026 Mark Sullivan Chief Legal Officer Other Acquisition +62,500 – 125,259
11 Aug 2026 Brandi Roberts Chief Financial Officer Other Acquisition +62,500 – 131,362
11 Aug 2026 Matthew Wiley Chief Commercial Officer Other Acquisition +62,500 – 237,133
11 Aug 2026 Robert Barrow Chief Executive Officer Other Acquisition +375,000 – 1,065,625
11 Aug 2026 Daniel Karlin Chief Medical Officer Other Acquisition +100,000 – 603,282
24 Jun 2026 Mark Sullivan Chief Legal Officer Automatic Disposition -13,008 $45.03 23,698

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 9,613,993 7.2% 5.8
15 Oct 2026 10,044,279 7.5% 4.9
30 Sep 2026 11,344,959 8.4% 4.9
15 Sep 2026 11,785,195 8.8% 5.2
31 Aug 2026 9,836,400 7.3% 5.6
14 Aug 2026 8,969,420 6.7% 3.4

Discussion

No comments yet — be the first to weigh in on DFTX.

Sign in to join the discussion.

Scroll to Top